ALK receptor activation, ligands and therapeutic targeting in glioblastoma and in other cancers

Abstract excerpt

The intracellular anaplastic lymphoma kinase (ALK) fragment shows striking homology with members of the insulin receptor family and was initially identified as an oncogenic fusion protein resulting from a translocation in lymphoma and more recently in a range of cancers. The full-length ALK transmembrane receptor of ~220 kDa was identified based on this initial work. This tyrosine kinase receptor and its ligands,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Glycosylation and Glycoproteins Research
• Share to Neuroblastoma Research and Treatments
• Share to Proteoglycans and glycosaminoglycans research